文献速递肿瘤 PET/CT

潜在陷阱:前列腺癌分期时[68Ga]-PSMA-11 PET/CT显示滤泡性淋巴瘤阳性

Potential Pitfall: Positive Follicular Lymphoma on [ 68 Ga]-PSMA-11 PET/CT for Prostate Cancer Staging.
PubMed 文献 · Clin Nucl Med · 2025-07-21

本文报道一例66岁前列腺癌患者,在行[68Ga]-PSMA-11 PET/CT分期时发现活检证实的滤泡性淋巴瘤呈PSMA阳性。该病例提示淋巴瘤可在PSMA PET/CT上模仿前列腺癌淋巴结转移,评估淋巴结分布与摄取时需仔细鉴别。

要点

  • PSMA靶向PET是高风险前列腺癌分期的支柱手段。
  • PSMA表达并非前列腺癌独有,也见于多种肿瘤和炎症状态。
  • 淋巴瘤可在PSMA PET/CT上模仿前列腺癌淋巴结转移,需仔细评估淋巴结分布与摄取。

核心结论

  • 本病例提示淋巴瘤在前列腺癌分期的PSMA PET/CT上模仿淋巴结转移是潜在陷阱。

研究设计与样本

  • 本文为病例报告,报道一例66岁前列腺癌患者行[68Ga]-PSMA-11 PET/CT分期。

主要发现

  • 该例活检证实的滤泡性淋巴瘤在[68Ga]-PSMA-11 PET/CT上呈阳性。

临床怎么用

  • 作者强调评估PSMA PET/CT时需仔细评价淋巴结的分布与摄取,以区分淋巴瘤与前列腺癌转移。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prostate-specific membrane antigen (PSMA)-targeted PET agents are a mainstay in staging high-risk prostate cancer. Nevertheless, PSMA expression is not exclusive to prostate cancer and is present in various neoplasms and inflammatory conditions. We report a case of biopsy-proven follicular lymphoma positive on PSMA PET/CT originally performed for staging of prostate cancer in a 66-year-old patient. This case highlights the potential pitfall of lymphoma mimicking prostate cancer nodal metastasis on PSMA PET/CT and the importance of careful evaluation of distribution and uptake of lymph nodes when assessing PSMA PET/CT studies to distinguish lymphoma from prostate cancer metastases.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Heniche Y, Abikhzer G, McPherson V, et al. Potential Pitfall: Positive Follicular Lymphoma on [ 68 Ga]-PSMA-11 PET/CT for Prostate Cancer Staging. Clin Nucl Med. 2025. PMID: 40694857. doi:10.1097/RLU.0000000000006062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。